Out-licensing: Drug Discovery & Cardiovascular/Acute Coronary Syndromes/Coronary Heart Disease

Latest: Watch here for details of new products and services.

About Us: Innovaro Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Pay-per-Click New!; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Innovaro Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..2 of 2 - per page
Order by

A new method for screening for enantiomeric excess which is colorimetric, rapid and sensitive. More

Gene-therapy product combining pCK naked DNA vector with genetically engineered Hepatocyte Growth Factor gene More

Displaying 1..2 of 2 - per page
Order by

Industry sector: Drug discovery del
Therapeutic target: Cardiovascular del; Acute coronary syndromes del; Coronary heart disease del

Industry sector: Bioinformatics; Combinatorial biology; Combinatorial chemistry; Drug research platforms; Genomics; High throughput screening; Proteomics
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Innovaro Pharmalicensing current industry press releases.